NasdaqCM - Delayed Quote
USD
BioNexus Gene Lab Corp. (BGLC)
1.4500
-0.0400
(-2.68%)
At close: September 4 at 4:00:00 PM EDT
1.4200
-0.0300
(-2.07%)
After hours: September 4 at 7:30:03 PM EDT
Loading chart for BGLC
- Previous Close
1.4900 - Open
1.3900 - Bid 0.9792 x 200
- Ask 1.8800 x 200
- Day's Range
1.3900 - 1.4500 - 52 Week Range
1.0700 - 6.1000 - Volume
740 - Avg. Volume
96,008 - Market Cap (intraday)
4.253M - Beta (5Y Monthly) 2.20
- PE Ratio (TTM)
-- - EPS (TTM)
-1.2400 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News
View MorePerformance Overview
Trailing total returns as of 9/4/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
BGLC
63.29%
S&P 500 (^GSPC)
12.75%
1-Year Return
BGLC
74.52%
S&P 500 (^GSPC)
18.71%
3-Year Return
BGLC
90.76%
S&P 500 (^GSPC)
70.93%
5-Year Return
BGLC
99.14%
S&P 500 (^GSPC)
70.18%
Statistics
View MoreValuation Measures
-
Market Cap
-
Enterprise Value
-
Trailing P/E
-
Forward P/E
-
PEG Ratio (5yr expected)
-
Price/Sales (ttm)
-
Price/Book (mrq)
-
Enterprise Value/Revenue
-
Enterprise Value/EBITDA
Financial Highlights
Profitability and Income Statement
-
Profit Margin
-82.36%
-
Return on Assets (ttm)
-18.99%
-
Return on Equity (ttm)
-33.66%
-
Revenue (ttm)
3.13M
-
Net Income Avi to Common (ttm)
-2.58M
-
Diluted EPS (ttm)
-1.2400
Balance Sheet and Cash Flow
-
Total Cash (mrq)
3.52M
-
Total Debt/Equity (mrq)
4.16%
-
Levered Free Cash Flow (ttm)
68.31k
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Mkt Cap
undefined
-
Industry
-
Mkt Cap
undefined
-
Industry
-
Mkt Cap
undefined
-
Industry
-
Mkt Cap
undefined
-
Industry
-
Mkt Cap
undefined
-
Industry
-
Mkt Cap
undefined
-
Industry
-
Mkt Cap
undefined
-
Industry
-
Mkt Cap
undefined
-
Industry
-
Mkt Cap
undefined
-
Industry
-
Mkt Cap
undefined
-
Industry
-
